Physician profile
Seth R Bender
NPI 1578740478
$41,330.33
in general payments reported to CMS, 2019-2025
18 companies · $8,360 in 2025
The $8,360 reported for 2025 was more than what 77% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,648 · 2020: $2,208 · 2021: $4,013 · 2022: $6,463 · 2023: $8,039 · 2024: $8,599 · 2025: $8,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Travel and Lodging: $4,149 · Consulting Fee: $2,000 · Education: $11.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,837.79 |
| Travel and Lodging | $4,149.33 |
| Consulting Fee | $2,000.00 |
| Education | $11.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,721.66 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $9,150.31 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Edora 8 Dr-T |
| Abbott Laboratories | $4,437.43 | 2019-2024 | Aveir, Amplatzer Amulet, Assurity |
| Medtronic Vascular, INC. | $2,399.97 | 2019-2020 | |
| Boston Scientific Corporation | $2,229.90 | 2019-2025 | Watchman Flx, General - Therapies, Versacross Access Solution |
| Biosense Webster, INC. | $1,844.05 | 2020-2025 | Qdot Micro Catheter, Qdot Micro, Octaray Mapping Catheter |
| Janssen Pharmaceuticals, INC | $663.73 | 2019-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $646.12 | 2021-2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $338.26 | 2019-2022 | |
| Atricure, INC. | $310.42 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Zoll Respicardia, INC. | $124.89 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.77 | 2021 | |
| Cardiva Medical, INC. | $110.04 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $99.84 | 2019-2024 | |
| Cordis US Corp. | $55.03 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $43.75 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $19.53 | 2022 | |
| Abiomed | $16.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.